openPR Logo
Press release

Pulmonary Dilation Balloon Market : Figures and Analytical Insights 2017-2027

12-19-2017 10:05 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Pulmonary Dilation Balloon Market : Figures and Analytical

The pulmonary dilation balloon is a technique used in the treatment of pulmonary valve stenosis. Pulmonary valve stenosis is an abnormality in which there is some deformity on or in the vicinity of the pulmonary valve, and this abnormality slows the blood flow. The pulmonary valve is the valve that aids the blood flow from the heart to lungs. In most of the cases, pulmonary valve stenosis develops before the birth of the person. In adults, if present pulmonary valve stenosis is present as a complication of some other illness. Pulmonary valve stenosis can be treated by some other methods also, but pulmonary dilation balloon has emerged as the most favored option over the past few years.

Pulmonary valve stenosis has emerged as a serious disease in the last few years. According to a report published on National Center for Biotechnology Information (NCBI) 7.5% - 9% diseases of all the congenital heart diseases is pulmonary valve stenosis. According to the data of CDC more than 40,000 children are born with congenital heart diseases in the U.S. alone. Other than this over 2million people in the U.S. are living with congenital heart diseases. This high prevalence of the disease illustrates the possibilities for the market of pulmonary dilation balloon.

Pulmonary Dilation Balloon Market: Drivers and Restraints

The major factors that are expected to drive the growth of the pulmonary dilation balloon market are an increase in the number of congenital heart diseases and early detection of the disease owing to the better medical facilities. Also, the minimally invasive method of pulmonary dilation balloon procedure is favoring its adoption over the conventional surgical methods. Pulmonary dilation balloon procedure also involves fewer complications and a success rate, thereby increasing the chances of market growth.

Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-3485

The major factors that can limit the growth of the pulmonary dilation balloon market are the complexity of the pulmonary valve stenosis in some patients that does not allow the use of pulmonary dilation balloon and demands surgical procedure.

Pulmonary Dilation Balloon Market: Overview

The market for pulmonary dilation balloon is expected to see higher growth in the forecast period due to the increase in the incidences of pulmonary valve stenosis in the past few years. The pulmonary dilation balloon is a procedure used to open up the blocked artery. The removal of the blockage helps in restoring the normal functionality of the artery and the valve, and thus pulmonary dilation balloon procedure is used in the treatment of pulmonary valve stenosis. The pulmonary dilation balloon is not as invasive as surgery, and this is one of the major reasons behind its success. But along with all these merits the major limitation that pulmonary dilation balloon procedure has, is the risk factors associated with the procedure in rare cases. But the long-term effects and the high success rate over powers the limitations of the pulmonary dilation balloon.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-3485

Pulmonary Dilation Balloon Market: Region-wise Outlook

North America and Europe are the most developed market in pulmonary dilation balloon due to the presence of the advanced healthcare infrastructure. Asia Pacific albeit has a higher number of pulmonary valve stenosis cases but the lack of awareness about pulmonary dilation balloon is responsible for the less usage of pulmonary dilation balloon in this region. Middle East and African countries are seeing an even less growth of the market due to lower GDP, but the growth is expected to increase worldwide due to high adoption rate.

Pulmonary Dilation Balloon Market: Key Market Participants

The key players of the market include Boston Scientific and Envaste Medical Instruments.

Pre Book Full Report – https://www.futuremarketinsights.com/checkout/3485

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Dilation Balloon Market : Figures and Analytical Insights 2017-2027 here

News-ID: 866990 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Pulmonary

Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments